With significant expertise in the technology and healthcare sectors, the fund manager has successfully executed over 50 deals across North America and Europe. His strategic focus on data-driven investments has led to several notable exits, including a high-profile sale in the biotech space. Active in the growth stage of investments, he emphasizes an operator-first approach, ensuring that portfolio companies are primed for scalable success. His analytical style is complemented by a keen understanding of market trends, further enhancing his ability to identify lucrative opportunities.